# Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

> **NCT01517984** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 52 (actual)

## Conditions studied

- Kidney Transplant Recipients

## Interventions

- **DRUG:** Tacrolimus (CNI) Withdrawal
- **DRUG:** Standard Immunosuppressive Therapy

## Key facts

- **NCT ID:** NCT01517984
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** Absence of equipoise on the basis of predetermined stopping rules.
- **Last updated:** 2017-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01517984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01517984, "Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01517984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*